SK Capital Partners, LP (SK Capital), a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, has completed the previously announced acquisition of LISI Group’s medical division.
The business has relocated its headquarters to Big Lake, Minnesota and has been renamed Precera Medical, marking its emergence as a contract development and manufacturing organization (CDMO) partner for blue chip medical device original equipment manufacturers (OEMs) and innovators. As part of the transaction, LISI Group retained a minority stake in the company.
Precera Medical is a CDMO focused on the production of high-precision components and assemblies serving global medical device OEMs. The company produces manufacturable solutions for applications including surgical robotics, minimally invasive surgery, orthopaedics, and interventional therapies. Precera Medical operates four manufacturing sites, two in Minnesota, US and two in France, with expertise in development, rapid prototyping, precision machining, precision forging and highly automated production.
Piper Sandler & Co, Jefferies LLC, and Sycomore Corporate Finance served as financial advisors and Kirkland & Ellis served as legal counsel to SK Capital. Debt financing was provided by Partners Group, acting on behalf of its clients, and Deutsche Bank’s Private Credit & Infrastructure and Corporate Bank Leveraged Finance teams. Rothschild & Co served as financial advisor and Dentons served as legal counsel to LISI Group.
